MedPath

TACHOSIL

TACHOSIL

Dormant
DIN Number

02439042

Drug Class

Human

Market Date

Sep 18, 2015

Company
HC

Corza Medical GmbH

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02439042
AIG Number0356730001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BC30 COMBINATIONS
Product Specifications
Dosage FormPatch
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (3)

COLLAGENActive
Strength: 2.1 MG / SQ CM
Monograph: COLLAGEN
FIBRINOGEN (HUMAN)Active
Strength: 5.5 MG / SQ CM
Monograph: FIBRINOGEN (HUMAN)
THROMBIN (HUMAN)Active
Strength: 2 UNIT / SQ CM
Monograph: THROMBIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.